Solthis Solidarité Thérapeutique et Initiatives pour la Santé

Do not wait for the crisis to act

Donate now

Infectious and emerging diseases

Since its creation, Solthis has always been invested in the fight against infectious diseases such as HIV, Tuberculosis and the Hepatitis B virus.  

Maladies infectieuses et emergentes

Today, Solthis continues its action and brings its expertise to fight emerging diseases such as Ebola (2015 in Guinea) and Covid-19. Indeed, although the Ebola epidemic has enabled health surveillance systems to be strengthened, epidemics still have a strong impact on the health of individuals and on already fragile health systems. In the context of the Covid-19 pandemic and the emergence of new infectious diseases, Solthis continues to invest in emerging diseases by targeting the following priorities in its actions:

  • diagnosis and management
  • adaptation of essential services during an epidemic crisis to enable continuity of care, especially for chronic diseases
  • prevention, including strengthening hygiene and infection control in health structures and within the community, sensitization and vaccination.

Learn more about Solthis’ work in the fight against HIV, tuberculosis, hepatitis B virus, Ebola and Covid-19.

Country action

GUINEASIERRA LEONEMALINIGER

Expertise

OPERATIONAL RESEARCHHEALTH INFORMATION SYSTEMCAPACITY BUILDINGSTRENGTHENING SYSTEMS AND HEALTH SERVICESHUMAN RESOURCES FOR HEALTHHEALTH PRODUCTS AND PHARMACEUTICAL SYSTEMLABORATORIES AND TECHNICAL PLATFORMSHEALTH FINANCINGGOVERNANCE AND HEALTH POLICIESADVOCACY FOR FAIR ACCESS TO QUALTITY HEALTH CARE

Health priority

Fighting HIV / AIDSFighting tuberculosisFighting HEPATITIS

Associated contents

JIKI TRIAL – Favipiravir Ebola Guinea – Publication in PLOSmedicine

2016 |  Research papers

GUINEAOPERATIONAL RESEARCHInfectious and emerging diseases

The INSERM and other partners of the JIKI trial, among which Alima, Doctors w/borders, the Red Cross published a research paper in PLOSmedicine : see this publication  The JIKI clinical trial seeked to test the effectiveness of Favirapir among people infected with the Ebola virus in Guinea. Solthis is pleased to have been able to participate in a modest degree to this project by facilitating the achievement of this trial on the spot through its team based in Conakry.

  Download resources

CROI 2016 : Access to HIV care in the health districts affected by the Ebola outbreak in Sierra Leone

2016 |  Posters

SIERRA LEONEHEALTH INFORMATION SYSTEMOPERATIONAL RESEARCHFighting HIV / AIDSInfectious and emerging diseases

Presentation of the poster “access to HIV care in the health districts affected by the Ebola outbreak in Sierra Leone” for the CROI 2016. Download the poster Jacques CROI 2016 Official Website : CROI 2016

  Download resources

CROI 2015: Solthis and Donka National Hospital Poster

2015 |  Posters

OPERATIONAL RESEARCHFighting HIV / AIDSInfectious and emerging diseases

Presentation of Solthis and Donka National Hospital poster on the 'impact of the Ebola outbreak on the quality of care of people living with HIV taking antiretroviral treatment at Donka National Hospital in Conakry, Guinea' More informations about CROI 2015

  Download resources

THE LANCET : Prevention of HIV spread during the Ebola outbreak in Guinea

2015 |  Scientific Papers

GUINEAOPERATIONAL RESEARCHFighting HIV / AIDSInfectious and emerging diseases

Author(s): J. NDawinz, M. Cissé, M. SK Diallo, C. T. Sidibé and E. D'Ortenzio Journal: The Lancet, April 11, 2015

  Download resources

Our projects

gifSolthisGB-300x300

Stay informed

Stay informed about our projects and news from Solthis by subscribing to our newsletter.

S'inscrire

© Solthis 2021 - All rights reserved | Legal notice | Personal data | Cookie Management | Sitemap